Header Logo

Connection

JOUD HAJJAR to Infusions, Intravenous

Back to Details
This is a "connection" page, showing publications JOUD HAJJAR has written about Infusions, Intravenous.
JOUD HAJJAR
Connection Strength
0.030
Infusions, Intravenous
  1. Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experience. Invest New Drugs. 2017 02; 35(1):59-67.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.